Number of employees
20
Annual revenue
$600000
Liquidia Technologies™ uses its innovative PRINT™ product platform to design, develop, and manufacture high-value products in the life science and materials science sectors. This platform allows the company to commercialize discrete nanoparticles and patterned films with complete precision of nanoscale features. Life science applications of the PRINT™ platform include targeted delivery therapeutics, drug product reformulations, and drug-device combination therapies. Applications in materials science include nano-engineered films and membranes for the management of light in display and photovoltaic devices.